Physician profile
Jennifer Dattolo
NPI 1962596627
$36,825.24
in general payments reported to CMS, 2019-2025
12 companies · $1,084 in 2025
The $1,084 reported for 2025 was more than what 96% of Vision Therapy providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,535 · 2020: $588 · 2021: $17K · 2022: $1,749 · 2023: $3,052 · 2024: $4,413 · 2025: $1,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,027 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,250 · Honoraria: $250 · Entertainment: $22.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,027.36 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,250.00 |
| Honoraria | $250.00 |
| Entertainment | $22.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Visioneering Technologies, INC. | $34,111.49 | 2019-2025 | |
| Johnson & Johnson Vision Care, INC. | $880.95 | 2019-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $832.20 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $245.44 | 2019-2021 | |
| Coopervision INC. | $235.85 | 2020-2025 | Myday Contact Lens, Clariti Contact Lens |
| Oyster Point Pharma, INC. | $142.24 | 2023-2024 | Tyrvaya |
| Tarsus Pharmaceuticals, INC. | $105.40 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $91.42 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $78.24 | 2025 | Tecnis Iol |
| Alcon Vision LLC | $61.34 | 2019 | |
| Optos, INC. | $22.08 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Harrow Eye, LLC | $18.59 | 2024 | Vevye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Dattolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.